Crossmark Global Holdings, Inc. Enanta Pharmaceuticals Inc Transaction History

Crossmark Global Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$40.22 - $62.0 $142,378 - $219,480	-3,540 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$57.95 - $66.61 $205,143 - $235,799	3,540 New	3,540 $219,000
Q4 2018 Jan 31, 2019	SELL	$65.41 - $84.65 $520,009 - $672,967	-7,950 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$85.46 - $126.37 $12,818 - $18,955	-150 Reduced 1.85%	7,950 $679,000
Q2 2018 Jul 31, 2018	BUY	$81.85 - $120.51 $34,377 - $50,614	420 Added 5.47%	8,100 $939,000
Q1 2018 Apr 16, 2018	SELL	$57.91 - $92.15 $35,904 - $57,133	-620 Reduced 7.47%	7,680 $621,000
Q4 2017 Feb 05, 2018	BUY	$45.65 - $59.37 $97,234 - $126,458	2,130 Added 34.52%	8,300 $487,000
Q3 2016 Oct 25, 2017	BUY	N/A	6,170	6,170 $289,000

112

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $110M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.